Details for New Drug Application (NDA): 211198
✉ Email this page to a colleague
The generic ingredient in MACITENTAN is macitentan. There are ten drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the macitentan profile page.
Summary for 211198
Tradename: | MACITENTAN |
Applicant: | Aurobindo Pharma Ltd |
Ingredient: | macitentan |
Patents: | 0 |
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 10MG | ||||
Approval Date: | Apr 18, 2023 | TE: | RLD: | No |
Complete Access Available with Subscription